Malignant glioma is the most frequently occurring primary brain tumor. Despite significant progress in the diagnostics and treatment of neoplastic diseases the prognosis for patients with III-IV grade gliomas, remains extremely unfavorable. Rapidly developing area in oncology is the employment of therapeutic viruses with natural or genetically engineered oncolytic activity. In the present study we demonstrated the oncolytic potential of a recombinant influenza A virus vector with impaired interferon antagonism function of NS1 protein in treatment of malignant glioma. Recombinant influenza A virus (HA-DS-GFP) expressing green fluorescent protein from the NS1 open reading frame was used as a model vector. HA-DS-GFP virus has shown infectivity towards glioma cells both in vitro, and in vivo (experimental glioma model in rats). Intratumoral inoculation of HA-DS-GFP resulted in a substantial inhibition or complete regression of tumor growth. Our data demonstrate that recombinant influenza vectors have promising potential in therapy of malignant gliomas.

Diagnostic properties of new monoclonal antibodies (MAbs) to hexon adenovirus antigen (AB) monoclonal ELISA kit for early diagnosis of adenoviral infection were tested. Developed ELISA kit and FITC-conjugate of new monocional antibodies for immunofluorescent analysis were used for detection of different types of adenoviruses in clinical materials. The availability of their use in clinical and epidemiological practice was validated.

Diagnostic properties of new monoclonal antibodies (MAbs) to hexon adenovirus antigen (AB) monoclonal ELISA kit for early diagnosis of adenoviral infection were tested. Developed ELISA kit and FITC-conjugate of new monoclonal antibodies for immunofluorescent analysis were used for detection of different types of adenoviruses in clinical materials. The availability of their use in clinical and epidemiological practice was validated.

In the surveillance of the incidence of rubella in the northwestern region of Russia, an analysis was conducted of swabs from the noses and pharynxes of 37 patients with rubella treated in Solovev District Military Clinical Hospital No. 442. To isolate the virus, the RK-13 cell line was used, in total 22 strains were allocated. The strains of the Rubella virus isolated in St. Petersburg during the 2007 outbreak belong to the 1E genotype. In the culture of RK-13 cells, changes of cellular morphogenesis and the formation of replicative complexes, as well as the shells of virions of rubella viruses, were detected.

The goal of this study was to evaluate the effect of Ingavirin® on the morphological features of the foci of adenovirus hepatitis in Syrian hamsters by electron microscopy. The use of the drug was shown to cause a substantial reduction in the rate of destructive processes and inflammatory reactions in the liver, by normalizing its structure at the levels of both tissue and individual hepatocytes. After administration of Ingavirin®, the morphogenesis of adenovirus infection in the infected hepatocytes did not differ from that in the controls; however, the infected cells were fewer. The proportion of morphologically inadequate virions in the presence of Ingavirin® increased from 35 to 46%. The findings suggest that Ingavirin® is an effective drug that has antiviral, anti-inflammatory, and cytoprotective activities in the focus of adenovirus tissue involvement

The goal of this study was to evaluate the effect of Ingavirin on the morphological features of the foci of adenovirus hepatitis in Syrian hamsters by electron microscopy. The use of the drug was shown to cause a substantial reduction in the rate of destructive processes and inflammatory reactions in the liver, by normalizing its structure at the levels of both tissue and individual hepatocytes. After administration of Ingavirin, the morphogenesis of adenovirus infection in the infected hepatocytes did not differ from that in the controls; however, the infected cells were fewer. The proportion of morphologically inadequate virions in the presence of Ingavirin increased from 35 to 46%. The findings suggest that Ingavirin is an effective drug that has antiviral, anti-inflammatory, and cytoprotective activities in the focus of adenovirus tissue involvement.

Human parainfluenza viruses cause damage of upper respiratory tract in patients of all age groups. The main antiviral drug is Ribavirin, which has severe side effects and is prescribed only at life-threatening conditions. The activity of Ingavirin against human parainfluenza virus was demonstrated in this work both in cell culture and in the model of parainfluenza pneumonia in Syrian hamsters using transmission electron microscopy. The application of Ingavirin is shown to reduce the number of progeny virions and cytopathic effect of the virus. The effect of Ingavirin was similar or exceeded that of ribavirin. In the in vivo experiments Ingavirin was shown to normalize the morphological structure of lungs, decreasing thereby the degree of destruction of alveolocytes. It also restricted budding of progeny virions and reduced the amount of inflammatory infiltrate. Thus, the combination of antiviral, cytoprotective, and anti-inflammatory properties makes Ingavirin an important component of comprehensive therapy of human parainfluenza infection.

The effect of meglumine salt of acridonoacetic acid (cycloferon) on the in vivo morphogenesis of influenza infection caused by viruses of different origin (avian, swine and human) and variable susceptibility to antivirals (rimantadine and oseltamivir) has been studied. The administration of cycloferon results in stimulation of the immune response, restriction of the foci of post-influenza pneumonia, and normalization of the structure of respiratory zones independently of the susceptibility or resistance of infectious virus to the drugs. Among virions formed in the lungs of cycloferon-treated mice, prevalence of irregular-shaped virions with defects of surface glycoproteins was observed. The data obtained suggest that cycloferon is a drug with the complex mechanism of activity.

The aim of this investigation was to study the effect of ingavirin on the structure and properties of influenza virions forming in its presence. The infectious activity of the virus and the morphology of the virions were analyzed by titration in cell culture and electron microscopy, respectively. The use of ingavirin was shown to reduce the proportion of morphologically intact virions and to increase that of filamentous and giant particles. No defects of surface glycoproteins were observed. The effect of the drug did not depend on the chosen model of virus replication and it was similarly shown in both cultured human cells and laboratory animals. In MDCK and A549 cells and in the mouse lungs, viral infectious activity was decreased by 1-2 orders of magnitude in relation to a model. The findings suggest that Ingavirin is able to impair the processes of viral morphogenesis, which in turn leads to a reduction in the infectivity of progeny virions.

Antiviral properties of Ingavirin were investigated in the Hep-2 cell culture with respect to the human respiratory tract virus (type 5 adenovirus). In concentrations of Ingavirin of 1000, 100 and 10 mcg/ml the generated posterity showed lower infective capacity (by 250, 100 and 10 times respectively). The electron microscopy of the infected cells confirmed the Ingavirin ability to disturb the adenovirus normal morphogenesis.

Therapy with anaferon (pediatric formulation) during the acute period of calicivirus infection shortened the duration of the main symptoms of the disease and period of virus release. Changes in the immunological status included increased production of IgA and IgM and activation of IFN-α synthesis.

A new type of solid-phase photosensitizer has been proposed and created on the basis of aggregated fullerene C60 for the photodynamic inactivation of pathogens in biological liquids. This paper demonstrates the chief advantage of such solid-phase systems, which is that efficient inactivation of pathogens (using influenza viruses as an example) by active forms of oxygen formed when a photosensitizer is irradiated in aqueous and biological media is combined with high photostability of the fullerene coatings and the possibility of completely extracting the photosensitizer from the biological medium after photodynamic activation.

The relationship between the structural and photosensitizing properties of solid-phase particles of fullerene C60 in aqueous suspensions is studied using the methods of absorption spectroscopy, electron spin resonance spectroscopy (ESR), X-ray diffraction, and spectrophotometry of solutions of singlet oxygen chemical traps—histidine in combination with p-nitrosodimethylaniline. Two new variants are proposed for obtaining aqueous suspensions of particles of solid-phase fullerene whose structures are disordered and whose degrees of amorphization are 67 and 40%, respectively. It is shown that an increase in the disorder of the structure of particles in suspensions and a decrease in their average size facilitate an increase in the formation efficiency of singlet oxygen by solid-phase fullerene presumably due to an in increase in the concentration of surface localized excitons.

The conditions of self-propagating high-temperature synthesis in a powdered sodium carbonate-magnesium mixture optimum for the preparation of the largest amount of carbon nanotubes (CNTs) were studied. The yield of nanotubes and nanofibers was weakly sensitive to the selection of the amount of a catalyst. The yield of nanotubes ceased to increase noticeably at a relative catalyst content higher than 10 wt %. For the first time, the self-propagating high-temperature reaction was performed with an iron-nickel catalyst in a limestone-magnesium mixture, that is, with the cheapest powdered reagent containing carbon. The reaction produced a small number of CNTs and nanofibers; cubic crystals, predominantly of MgO, were also observed.